首页 | 本学科首页   官方微博 | 高级检索  
     

5%咪喹莫特乳膏治疗尖锐湿疣的临床研究
引用本文:陶苏江,顾军,赵广,李明. 5%咪喹莫特乳膏治疗尖锐湿疣的临床研究[J]. 中国皮肤性病学杂志, 2006, 20(3): 147-148,160
作者姓名:陶苏江  顾军  赵广  李明
作者单位:1. 上海长海医院皮肤科,上海,200433
2. 北京空军总医院皮肤科,北京,100036
3. 上海复旦大学中山医院,上海,200032
摘    要:目的探讨5%咪喹莫特乳膏治疗尖锐湿疣的有效性和安全性。方法采用多中心、随机、双盲、安慰剂平行对照法对236例尖锐湿疣患者进行了8周的临床研究。结果有116例治疗组患者和120例对照组患者完成临床观察并纳入统计分析。两组治疗后2周、6周及治疗后8周在疗效评价方面有显著差异(P<0.05),不良反应主要是轻至中度的红斑、水肿、糜烂、刺痛及瘙痒。结论5%咪喹莫特乳膏是一种治疗外生殖器疣有效而安全的新药。

关 键 词:咪喹莫特乳膏  尖锐湿疣  有效性  安全性
文章编号:1001-7089(2006)03-0147-02
收稿时间:2005-06-27
修稿时间:2005-06-272005-11-20

Evaluation of Topical 5% Imiquimod Cream on the Treatment of Condylomata Acuminata
TAO Su-jiang, GU Jun, ZHAO Guang, et al. Evaluation of Topical 5% Imiquimod Cream on the Treatment of Condylomata Acuminata[J]. The Chinese Journal of Dermatovenereology, 2006, 20(3): 147-148,160
Authors:TAO Su-jiang   GU Jun   ZHAO Guang   et al
Affiliation:Department of Dermatology, Changhai Hospital,Shanghai 200433, China
Abstract:Objective To evaluate the efficacy and safety of topical 5% imiquimod cream in the treatment of condylomata acuminate.Methods A double-blind,controlled study in which patients with condylomata acuminate were randomized to 8 weeks of treatment with 5% imiquimod cream or the cream base.Results 116 patients were randomized to topical 5% imiquimod cream and 120 patients to placebo.Significant difference of efficacy between the two groups were observed after weeks of 2,6 and 8(P<0.05).The most common adverse effects were slight or moderate erythema,edema,erosion and itching.Conclusion Topical 5% imiquimod cream is effective and safe therapy for extra-genital warts.
Keywords:Imiquimod cream   Condylomata acuminate    Efficacy    Safety
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号